ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8%
Tue, 19 Jan

ALEMBIC PHARMA has announced its results for the quarter ended December 2020. Here is a detailed performance review of the same:

ALEMBIC PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-19*
3
Sep-20*
3
Dec-20*
QoQ ChangeYoY Change
Net SalesRs m12,09114,57113,143-9.8%8.7%
Other incomeRs m43225-21.3%518.3%
TurnoverRs m12,09514,60313,169-9.8%8.9%
ExpensesRs m8,84110,1379,492-6.4%7.4%
Gross profitRs m3,2514,4343,651-17.7%12.3%
DepreciationRs m4184384707.3%12.3%
InterestRs m744523-48.4%-68.6%
Profit before taxRs m2,7633,9843,183-20.1%15.2%
TaxRs m486730591-19.0%21.7%
Profit after taxRs m2,2773,2542,592-20.3%13.8%
Gross profit margin%26.930.427.8
Effective tax rate%17.618.318.6
Net profit margin%18.822.319.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 8.7% on a year-on-year (YoY) basis. The expenses were up by 7.4% YoY during the same period.
  • The company's operating profit increased by 12.3% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.8% in 3QFY21 as against 26.9% in 3QFY20.
  • Depreciation charges increased by 12.3% and finance costs declined by 68.6% YoY, respectively.
  • Other income increased by 518.3% YoY during the quarter.
  • Net profit for the quarter increased by 13.8% YoY. Net profit margins during the quarter increased from 18.8% in 3QFY20 to 19.7% in 3QFY21.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 9.8% on a quarter-on-quarter (QoQ) basis. The expenses were down by 6.4% QoQ during the same period.
  • The company's operating profit declined by 17.7% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 27.8% in 3QFY21 as against 30.4% in 2QFY20.
  • Net profit for the quarter declined by 20.3% QoQ, while net profit margins declined from 22.3% in 2QFY20 to 19.7% in 3QFY21.

To see how ALEMBIC PHARMA has performed over the last eight quarters,please visit here.

ALEMBIC PHARMA Share Price Performance

Over the last one year, ALEMBIC PHARMA share price has moved up from Rs 603.6 to Rs 1,033.8, registering a Gain of Rs 430.2 or around 71.3%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 21,853.9 (up 1.5%). Over the last one year it has moved up from 14,051.2 to 21,853.9, a gain of 7,803 points (up 55.5%).

Overall, the S&P BSE SENSEX is up 18.0% over the year.

Current Valuations

At the current price of Rs 1,033.8, the price to earnings (P/E) ratio of ALEMBIC PHARMA stands at 18.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 7.2 times.

Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8%". Click here!

  

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Feb 26, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - AJANTA PHARMA COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS